Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patients ; volume:23 ; number:1 ; day:5 ; month:7 ; year:2024 ; pages:1-7 ; date:12.2024
Molecular cancer ; 23, Heft 1 (5.7.2024), 1-7, 12.2024
- Creator
-
Hovorkova, Lenka
Winkowska, Lucie
Skorepova, Justina
Krumbholz, Manuela
Benesova, Adela
Polivkova, Vaclava
Alten, Julia
Bardini, Michela
Meyer, Claus
Kim, Rathana
Trahair, Toby N.
Clappier, Emmanuelle
Chiaretti, Sabina
Henderson, Michelle
Sutton, Rosemary
Sramkova, Lucie
Stary, Jan
Machova Polakova, Katerina
Marschalek, Rolf
Metzler, Markus
Cazzaniga, Giovanni
Cario, Gunnar
Trka, Jan
Zaliova, Marketa
Zuna, Jan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12943-024-02053-4
- URN
-
urn:nbn:de:101:1-2409232117544.423150077880
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hovorkova, Lenka
- Winkowska, Lucie
- Skorepova, Justina
- Krumbholz, Manuela
- Benesova, Adela
- Polivkova, Vaclava
- Alten, Julia
- Bardini, Michela
- Meyer, Claus
- Kim, Rathana
- Trahair, Toby N.
- Clappier, Emmanuelle
- Chiaretti, Sabina
- Henderson, Michelle
- Sutton, Rosemary
- Sramkova, Lucie
- Stary, Jan
- Machova Polakova, Katerina
- Marschalek, Rolf
- Metzler, Markus
- Cazzaniga, Giovanni
- Cario, Gunnar
- Trka, Jan
- Zaliova, Marketa
- Zuna, Jan
- SpringerLink (Online service)
Other Objects (12)
FISH mapping of Philadelphia negative BCR/ABL1 positive CML
Mast cell deficiency prevents BCR::ABL1 induced splenomegaly and cytokine elevation in a CML mouse model
Mast cell deficiency prevents BCR::ABL1 induced splenomegaly and cytokine elevation in a CML mouse model
Chronic phase CML with sole P190 (e1a2) BCR::ABL1: long-term outcome among ten consecutive cases
Genomische BCR-ABL1-Bruchpunkte bei kindlichen Leukämien
MicroRNA und mRNA Expressionsmuster bei BCR-ABL1-positiver CML und JAK2 p. V617F-positiven chronisch-myeloproliferativen Erkrankungen
BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene
Higher prevalence of harbouring BCR::ABL1 in first-degree relatives of chronic myeloid leukaemia (CML) patients compared to normal population
Approach to Diagnosis of BCR::ABL1-Negative Myeloproliferative Neoplasms
Targeting Poly(ADP)ribose polymerase in BCR/ABL1-positive cells
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1
Impact of BCR::ABL1 single nucleotide variants on asciminib efficacy
FISH mapping of Philadelphia negative BCR/ABL1 positive CML
Mast cell deficiency prevents BCR::ABL1 induced splenomegaly and cytokine elevation in a CML mouse model
Mast cell deficiency prevents BCR::ABL1 induced splenomegaly and cytokine elevation in a CML mouse model
Chronic phase CML with sole P190 (e1a2) BCR::ABL1: long-term outcome among ten consecutive cases
Genomische BCR-ABL1-Bruchpunkte bei kindlichen Leukämien
MicroRNA und mRNA Expressionsmuster bei BCR-ABL1-positiver CML und JAK2 p. V617F-positiven chronisch-myeloproliferativen Erkrankungen
BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene
Higher prevalence of harbouring BCR::ABL1 in first-degree relatives of chronic myeloid leukaemia (CML) patients compared to normal population
Approach to Diagnosis of BCR::ABL1-Negative Myeloproliferative Neoplasms
Targeting Poly(ADP)ribose polymerase in BCR/ABL1-positive cells
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1
Impact of BCR::ABL1 single nucleotide variants on asciminib efficacy
FISH mapping of Philadelphia negative BCR/ABL1 positive CML
Mast cell deficiency prevents BCR::ABL1 induced splenomegaly and cytokine elevation in a CML mouse model
Mast cell deficiency prevents BCR::ABL1 induced splenomegaly and cytokine elevation in a CML mouse model
Chronic phase CML with sole P190 (e1a2) BCR::ABL1: long-term outcome among ten consecutive cases
Genomische BCR-ABL1-Bruchpunkte bei kindlichen Leukämien
MicroRNA und mRNA Expressionsmuster bei BCR-ABL1-positiver CML und JAK2 p. V617F-positiven chronisch-myeloproliferativen Erkrankungen
BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene
Higher prevalence of harbouring BCR::ABL1 in first-degree relatives of chronic myeloid leukaemia (CML) patients compared to normal population
Approach to Diagnosis of BCR::ABL1-Negative Myeloproliferative Neoplasms
Targeting Poly(ADP)ribose polymerase in BCR/ABL1-positive cells
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1